Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.


Welcome to our discussion on medical malpractice
James R. Copland,, 11-10-04

Given the explosion of Vioxx litigation, and other pharmaceutical related liability issues (regarding vaccines, bioterrorism, etc.), we would like to introduce our readers to our sister website, “Point of Law” (, which focuses on reforms and debates related to America’s runaway tort litigation system. More information legal issues can be found at the Manhattan Institute’s Center for Legal Policy, at

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000